| Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy (NCT04435028) | Horus University | 2019-01-14 |
| Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors (NCT02856503) | Eli Avisar, MD | 2019-01-13 |
| Breast Cancer Self-Management Mobile Care Application Intervention in the Quality of Life (NCT04174248) | National Yang Ming Chiao Tung University | 2019-01-11 |
| A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer (NCT03726879) | Hoffmann-La Roche | 2019-01-11 |
| Real World Study of Lapatinib Among Metastatic Breast Cancer Patients (NCT03894410) | Fudan University | 2019-01-10 |
| ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC (NCT04172259) | Sun Yat-sen University | 2019-01-10 |
| Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1 (NCT03630809) | H. Lee Moffitt Cancer Center and Research Institute | 2019-01-10 |
| CDK and Body Composition Study (NCT03697577) | Montefiore Medical Center | 2019-01-08 |
| Family History in a Singapore Oncology Population (NCT04639934) | Duke University | 2019-01-07 |
| Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers (NCT03790813) | British Columbia Cancer Agency | 2019-01-07 |
| Distress Reduction by Activity Tracking and Activity Enhancement by Mobile Support Group in Oncology (NCT03783481) | Asan Medical Center | 2019-01-07 |
| Cancer Activity and Lifestyle Measurement Study (NCT03961685) | Ohio State University | 2019-01-04 |
| RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S. (NCT04460898) | Pfizer | 2019-01-04 |
| Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography (NCT04397029) | George Washington University | 2019-01-04 |
| A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer (NCT03200704) | Novadaq Technologies ULC, now a part of Stryker | 2019-01-04 |
| Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS (NCT03703492) | University of Wisconsin, Madison | 2019-01-03 |
| 18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer (NCT03790423) | Rigshospitalet, Denmark | 2019-01-03 |
| Liquid Biopsies and Imaging in Breast Cancer (NCT04223492) | UMC Utrecht | 2019-01-02 |
| Evaluating the Impact of Evidence-based Information About Mammography on Breast Cancer Screening Decisions (NCT03631758) | McMaster University | 2019-01-01 |
| Added Value of Contrast-enhanced Ultrasound for BI RADS 4A Nodules (NCT04929132) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2019-01-01 |
| The Influence of Treatment Position (Prone vs. Supine) on Whole Breast Target (NCT05609058) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-01-01 |
| Toxicity Outcomes of Simultaneous Integrated Boost in Adjuvant Breast Radiotherapy Acronym (NCT07407192) | Institute of Oncology Ljubljana | 2019-01-01 |
| Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines (NCT05728632) | Giulio Stefanini | 2019-01-01 |
| Closed Incision Disposable Negative Pressure Wound Therapy in Immediate Postmastectomy Breast Reconstruction (NCT04808765) | University in Zielona Góra | 2019-01-01 |
| CEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective Study (NCT05797129) | Kaohsiung Veterans General Hospital. | 2019-01-01 |
| Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism (NCT00960544) | M.D. Anderson Cancer Center | 2019-01-01 |
| Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. (NCT03992664) | Cyprus University of Technology | 2019-01-01 |
| Sentinel Lymph Node Biopsy With Hybrid Technique in Breast Cancer (NCT04274946) | Bulent Ecevit University | 2019-01-01 |
| IGAR-Breast TeleOp Trial (NCT03734432) | McMaster University | 2019-01-01 |
| Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer (NCT03851497) | Peking Union Medical College Hospital | 2019-01-01 |
| Autotaxin: a Potential Biomarker for Breast Cancer. (NCT05680311) | Ankara Etlik City Hospital | 2019-01-01 |
| Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor (NCT03518268) | Tel-Aviv Sourasky Medical Center | 2019-01-01 |
| Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis (NCT04137406) | Peking University People's Hospital | 2019-01-01 |
| Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung Cancer (NCT04960735) | Biosistemak Institute for Health Systems Research | 2019-01-01 |
| Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer (NCT05880927) | Taizhou Hospital | 2019-01-01 |
| The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery (NCT03782896) | Samsung Medical Center | 2018-12-31 |
| Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) (NCT03725059) | Merck Sharp & Dohme LLC | 2018-12-27 |
| Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] (NCT03734029) | Daiichi Sankyo | 2018-12-27 |
| FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer (NCT03944434) | Fondazione Sandro Pitigliani | 2018-12-27 |
| Clinico-biological Data Collection Study of Metastatic Breast Cancer (NCT03958136) | Institut Cancerologie de l'Ouest | 2018-12-24 |
| A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer (NCT03933982) | Chinese Academy of Medical Sciences | 2018-12-22 |
| Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications (NCT03845907) | Seno Medical Instruments Inc. | 2018-12-19 |
| Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets (NCT03661892) | University of Arizona | 2018-12-19 |
| Prospective Trial of Digital Breast Tomosynthesis (DBT) in Breast Cancer Screening. (NCT03733106) | King's College Hospital NHS Trust | 2018-12-17 |
| Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors (NCT03689192) | Herlev Hospital | 2018-12-17 |
| A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers (NCT04688086) | Niramai Health Analytix Private Limited | 2018-12-15 |
| Screening For BCRL In Targeted Therapy For Breast Cancer (NCT05142800) | Massachusetts General Hospital | 2018-12-13 |
| Screening Contrast-enhanced Mammography (NCT05390229) | CHU de Quebec-Universite Laval | 2018-12-12 |
| TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer (NCT03694756) | Montefiore Medical Center | 2018-12-12 |
| A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer (NCT03956654) | Universitaire Ziekenhuizen KU Leuven | 2018-12-11 |
| Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer (NCT04580784) | Mona Salem | 2018-12-10 |
| T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer (NCT03530696) | University of Arizona | 2018-12-06 |
| Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back (NCT05095675) | European Institute of Oncology | 2018-12-06 |
| PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo (NCT04149353) | UNC Lineberger Comprehensive Cancer Center | 2018-12-05 |
| Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients (NCT03787056) | Hospices Civils de Lyon | 2018-12-04 |
| Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53 (NCT04966923) | Instituto do Cancer do Estado de São Paulo | 2018-12-02 |
| The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer (NCT03756090) | Zhejiang Cancer Hospital | 2018-12-01 |
| The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer (NCT03647280) | Zhejiang Cancer Hospital | 2018-12-01 |
| Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies (NCT02822196) | The University of Texas Health Science Center, Houston | 2018-12-01 |
| Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt (NCT03696004) | Assiut University | 2018-12-01 |
| The LightPath® and 68Ga-RM2 in Breast Cancer Study (NCT03731026) | Lightpoint Medical Limited | 2018-11-30 |
| A Study of ZN-c5 in Subjects With Breast Cancer (NCT03560531) | Zeno Alpha Inc. | 2018-11-30 |
| Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC (NCT03361800) | UNC Lineberger Comprehensive Cancer Center | 2018-11-28 |
| Descriptive Observational Study of the Evolution of the Lifestyle Alteration in Patients With Breast Cancer (NCT03712176) | Hospices Civils de Lyon | 2018-11-27 |
| HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases (NCT03696030) | City of Hope Medical Center | 2018-11-27 |
| Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools (NCT04626440) | vghtpe user | 2018-11-22 |
| Local Compression Seroma DIminution Objective (CLODIS) (NCT03598712) | Centre Francois Baclesse | 2018-11-18 |
| Exercise in Older Women With Breast Cancer During Systemic Therapy (NCT03656731) | Herlev and Gentofte Hospital | 2018-11-15 |
| Imagio Feasibility Multi-Reader, Multi-Case Study (NCT03708393) | Seno Medical Instruments Inc. | 2018-11-13 |
| Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer (NCT03573648) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-13 |
| Hypofractionated Regional Nodal Irradiation in Breast Cancer (NCT06443359) | Corewell Health East | 2018-11-13 |
| The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer (NCT03880799) | Endeavor Health | 2018-11-08 |
| Topical Calcipotriene Treatment for Breast Cancer Immunoprevention (NCT03596073) | Massachusetts General Hospital | 2018-11-07 |
| Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (NCT03769415) | UNC Lineberger Comprehensive Cancer Center | 2018-11-06 |
| Reducing Metabolic Syndrome Among Breast Cancer Survivors (NCT03719677) | Barbara Ann Karmanos Cancer Institute | 2018-11-06 |
| DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC (NCT03716180) | Dana-Farber Cancer Institute | 2018-11-05 |
| Artificial Intelligence vs Physicians for Breast Cancer Patients' Information (NCT03556813) | Wefight | 2018-11-01 |
| Opera® for Aromatase Inhibitor-related Arthralgia Management (AIA) (NCT04161833) | Azienda Ospedaliero-Universitaria Careggi | 2018-11-01 |
| Marital Satisfaction and Sexual Health of Female Cancer Patients in Singapore (NCT03420547) | Duke-NUS Graduate Medical School | 2018-11-01 |
| Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer (NCT03735082) | Chinese Academy of Medical Sciences | 2018-11-01 |
| Speeding Recovery From Pain and Opioid Use (NCT03388814) | Wake Forest University Health Sciences | 2018-11-01 |
| Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer (NCT03058939) | University of Chicago | 2018-11-01 |
| Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors (NCT03755739) | Second Affiliated Hospital of Guangzhou Medical University | 2018-11-01 |
| Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes (NCT03718455) | Mayo Clinic | 2018-10-30 |
| ALEXANDRIA Study Egypt (NCT03583463) | AstraZeneca | 2018-10-29 |
| Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer (NCT03904173) | Oslo University Hospital | 2018-10-29 |
| Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells (NCT03634501) | Xuanwu Hospital, Beijing | 2018-10-26 |
| Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy (NCT03723863) | University of Washington | 2018-10-25 |
| Food Effect Study of D-0502 Tablet in Healthy Volunteers (NCT03810625) | InventisBio Co., Ltd | 2018-10-23 |
| Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer (NCT03697551) | Ipsen | 2018-10-22 |
| Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer (NCT03628066) | NSABP Foundation Inc | 2018-10-22 |
| East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction (NCT04344496) | National Taiwan University Hospital | 2018-10-18 |
| Calming Alternatives Learned During MRI-Guided Breast Biopsy (NCT03877146) | Duke University | 2018-10-16 |
| Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer (NCT03433313) | EirGenix, Inc. | 2018-10-16 |
| Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer (NCT03946579) | Centre Henri Becquerel | 2018-10-16 |
| Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (NCT03488693) | Canadian Cancer Trials Group | 2018-10-16 |
| Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer (NCT03982485) | RenJi Hospital | 2018-10-16 |
| Responsiveness to Acute Changes in Exercise and Relaxation (RACER) Trial (NCT03702712) | University of Illinois at Urbana-Champaign | 2018-10-15 |
| A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer (NCT03280134) | Zhejiang Cancer Hospital | 2018-10-15 |
| Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes (NCT03684096) | University Hospital, Ghent | 2018-10-15 |